Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Role of Exosomes in Myeloid and Lymphoid Blood Malignancies: A Systematic Review Article



Maleki A1 ; Khatib ZK2 ; Alizadeh S3 ; Hamidieh AA4 ; Pourfatollah AA5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Sciences Student in Laboratory Hematology and Blood Banking, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Laboratory Hematology and Blood Banking, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
  3. 3. Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Pediatric Stem Cell Transplant, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Medical Immunology, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran

Source: Journal of Payavard Salamat Published:2021

Abstract

Background and Aim: Blood malignancies, one of the most common cancers in the world, cause a large number of deaths each year. Many inherited and acquired factors are involved in the development of this disease. Exosomes are a very small model of cells that are secreted by most cells in the body under physiological and pathological conditions. On the other hand, they have found a special place in the treatment of these diseases because of their very small structure and biodegradability. Materials and Methods: This study is a systematic review article. For this study, the electronic databases such as PubMed, Scopus and Web of Science were reviewed and 110 original and review articles were studied from 2000 to 2020. Exosome, blood malignancies and immunotherapy were used as keywords along with a number of other related terms such as tumor microenvironment, acute myeloid leukemia, acute lymphoid leukemia, chronic lymphoid leukemia and multiple myeloma (Exosome AND Leukemia, Leukemia AND Immunotherapy, Exosome AND Cancer, AML AND Exosome) to search in these databases. Finally, 51 sources that related to exosomes and myeloid and lymphoid blood malignancies were used. Results: The genomic profile of malignant cells and tumor microenvironment changes in the conditions of the disease. The contents of exosomes released by leukemic cells, including anti-apoptotic proteins, various microRNAs, angiogenic agents, heat shock proteins and oncogenes involved in the development of inflammatory phenotype in the target cells, are known as factors involved in the pathogenesis of leukemia. A variety of therapeutic materials such as anti-inflammatory drugs, recombinant proteins, siRNA and the inhibitor of various microRNAs can also be packaged in the exosomes with several ways and used to treat leukemia. Conclusion: Exosomes derived from malignant cells play the important role in the growth and proliferation, angiogenesis, metastasis, resistance to chemotherapeutic agent, and the escape of cancer cells from the immune system by the modification of tumor microenvironment. The role of exosomes in the creation and development of blood malignancies has been proven. Therefore, using of them will probably be very helpful and promising in the treatment of these disorders with various forms. © 2021 Tehran University of Medical Sciences.
Related Docs
View other Related Docs
1. Harnessing the Power of Exosomes for Diagnosis, Prognosis, and Treatment of Hematological Malignancies, Stem Cell Research and Therapy (2025)
2. Exosome Application in Treatment and Diagnosis of B-Cell Disorders: Leukemias, Multiple Sclerosis, and Arthritis Rheumatoid, Cellular and Molecular Biology Letters (2022)
3. Recent Advances in the Roles of Exosomal Micrornas (Exomirs) In Hematologic Neoplasms: Pathogenesis, Diagnosis, and Treatment, Cell Communication and Signaling (2023)
4. Extracellular Vesicles: Regenerative Medicine Prospect in Hematological Malignancies, Cell Biology International (2021)
5. Extracellular Microvesicles: Biologic Properties, Biogenesis, and Applications in Leukemia, Molecular and Cellular Biochemistry (2024)
6. Communication Between Stromal and Hematopoietic Stem Cell by Exosomes in Normal and Malignant Bone Marrow Niche, Biomedicine and Pharmacotherapy (2020)
7. The Emerging Role of Exosomes in Multiple Myeloma, Blood Reviews (2019)
8. Extracellular Vesicles in Acute Leukemia: A Mesmerizing Journey With a Focus on Transferred Micrornas, Frontiers in Cell and Developmental Biology (2021)
Experts (# of related papers)
View all Related Experts
Hamid Reza Mirzaei (2)
Amir Ali Hamidieh (2)
Other Related Docs
9. Inhibition of Exosome Release Sensitizes U937 Cells to Pegylated Liposomal Doxorubicin, Frontiers in Immunology (2021)
10. Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy, Frontiers in Immunology (2020)
11. Mesenchymal Stem Cell-Derived Exosomes: A Novel Therapeutic Frontier in Hematological Disorders, Medical Oncology (2025)
12. State of the Art in Microrna As Diagnostic and Therapeutic Biomarkers in Chronic Lymphocytic Leukemia, Journal of Cellular Physiology (2018)
13. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
14. Exosomes From Adipose Tissue-Derived Mesenchymal Stem Cells Induce Regulatory T Cells in Covid‐19 Patients, Iranian Journal of Allergy# Asthma and Immunology (2023)
15. Modifying Exosome Release in Cancer Therapy: How Can It Help?, Pharmacological Research (2018)
16. Exosomal Circrnas: New Players in Colorectal Cancer, Cancer Cell International (2021)
17. Current Knowledge on Therapeutic, Diagnostic, and Prognostics Applications of Exosomes in Multiple Myeloma: Opportunities and Challenges, Archives of Biochemistry and Biophysics (2024)
18. Cancer Exosomes and Natural Killer Cells Dysfunction: Biological Roles, Clinical Significance and Implications for Immunotherapy, Molecular Cancer (2022)
19. Small Extracellular Vesicle Tgf-Β in Cancer Progression and Immune Evasion, Cancer Gene Therapy (2023)
20. Exosomal Noncoding Rnas: Key Players in Glioblastoma Drug Resistance, Molecular and Cellular Biochemistry (2021)
21. Extracellular Vesicles-Based Drug Delivery Systems: A New Challenge and the Exemplum of Malignant Pleural Mesothelioma, International Journal of Molecular Sciences (2020)
22. Antileukemia Activity of Human Natural Killer Cell-Derived Nanomagic Bullets Against Acute Myeloid Leukemia (Aml), International Journal of Hematology-Oncology and Stem Cell Research (2024)
23. Exosome Engineering in Cell Therapy and Drug Delivery, Inflammopharmacology (2023)
24. Aml-Derived Extracellular Vesicles Confer De Novo Chemoresistance to Leukemic Myeloblast Cells by Promoting Drug Export Genes Expression and Ros Inhibition, Iranian Journal of Pharmaceutical Research (2021)
25. Potential Role of Exosome in Post-Stroke Reorganization And/Or Neurodegeneration, EXCLI Journal (2020)
26. Current Understanding of the Exosomes and Their Associated Biomolecules in the Glioblastoma Biology, Clinical Treatment, and Diagnosis, Journal of Neuroimmune Pharmacology (2025)
27. Current Understanding of Therapeutic and Diagnostic Applications of Exosomes in Pancreatic Cancer, Pancreas (2025)
28. Tumor-Derived Exosomes: The Next Generation of Promising Cell-Free Vaccines in Cancer Immunotherapy, OncoImmunology (2020)
29. Microvesicles of Osteoblasts Modulate Bone Marrow Mesenchymal Stem Cell-Induced Apoptosis to Curcumin in Myeloid Leukemia Cells, Journal of Cellular Physiology (2019)